Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)

计划入组 200 人 · 首次发布于 2023 年 10 月 10 日

Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials

计划入组 30 人 · 首次发布于 2026 年 4 月 21 日

Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions

计划入组 1,300 人 · 首次发布于 2022 年 3 月 16 日

Eprosartan(Teveten HCT)

C₂₃H₂₄N₂O₄S · Rx

Losartan(Hyzaar, Cozaar)

C₂₂H₂₃ClN₆O · Rx

APROS THERAPEUTICS, INC.

United States

Repros Therapeutics Inc.

United States

Empros Pharma AB

Sweden

Digital Evolution in Clinical Trials: ePROs Show 97% Compliance Rate in Latest Study

Digital Study Design Optimizes Patient Engagement and Data Completeness in Rheumatoid Arthritis Research

AI-Powered Remote Monitoring Shows Promise for Reducing Patient Burden in Clinical Trials